Skip to main content
Live clinical studies

Remote monitoring for more proactive IBD care

IBDi is a digital monitoring platform for inflammatory bowel disease, combining patient-reported data, home fecal calprotectin testing, and clinician-reviewed monitoring to support more structured follow-up between visits.

IBDi patient app shown on three iPhones: splash screen, daily overview, and symptom score.

The challenge

IBD care needs better visibility between visits

IBD care often depends on scheduled visits, patient-initiated contact, and isolated test results. Disease activity can change between visits, and symptoms do not always reflect intestinal inflammation.

At the same time, IBD clinics face increasing pressure from growing patient numbers, more complex treatments, and limited specialist resources.

Clinical illustration showing limited IBD care visibility between clinic visits, with patient-reported signals connecting a mobile app to a clinician dashboard.

The IBDi platform

A connected monitoring workflow, not just an app

IBDi connects a patient's home-monitoring routine with a clinician-facing interface and home biomarker testing.

Patient app

Symptom reporting, medication routines, quality-of-life reporting, and home-test workflow.

Clinical review

Patient overview, notifications, graphs, comments, and follow-up support for clinical teams.

Home calprotectin

Calpro Smart DeepLink integration for home fecal calprotectin as part of structured monitoring.

How monitoring works

A simple loop, end to end

Step 1

Clinic enrols patient

Step 2

Activation code

Step 3

Patient reports + tests

Step 4

Clinical review

Step 5

Clinician follow-up

Current state and roadmap

Clear about what exists today

We separate what the current platform does from where it is heading.

Current

What IBDi supports today

  • Symptom and medication reporting
  • Quality-of-life reporting
  • Home fecal calprotectin workflow
  • Clinical review by the care team
Roadmap

Where it is heading

  • Improved UX and lower patient burden
  • Richer longitudinal signals and wearables
  • Education and adherence support
  • Carefully governed analytics and integration
Live clinical studies

Clinical studies are live using the current version

The studies evaluate structured remote monitoring, home-based testing, and redesigned care workflows. IBDi is building an evidence base for more proactive follow-up between visits.

Current study status

  • Live clinical studies

    Recruiting and actively collecting data

  • Study-linked use

    Remote monitoring with clinician-reviewed follow-up

  • Governance boundary

    Not for autonomous diagnosis, prediction, or treatment recommendations

Interested in IBDi?

For questions about the platform, clinical studies, collaboration, or implementation, get in touch with the team.